Wambeke David J. 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Wambeke David J.
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2025-06-01+250,000→ 250,000 totalExercise: $4.11Exp: 2035-05-31→ Common Shares (250,000 underlying)
Holdings
- 527,114
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026.